Racial Differences in Outcomes With Dabigatran in Elderly Atrial Fibrillation Patients

被引：0
作者：
Kabra, Rajesh
Vaughan-Sarrazin, Mary
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Atrial fibrillation; Dabigatran; Outcomes;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19749
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Sex Differences in Dabigatran Use, Safety, And Effectiveness In a Population-Based Cohort of Patients With Atrial Fibrillation
    Tsadok, Meytal Avgil
    Jackevicius, Cynthia A.
    Rahme, Elham
    Humphries, Karin H.
    Pilote, Louise
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (06): : 593 - 599
  • [22] Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation
    Rillig, Andreas
    Lin, Tina
    Plesman, Joaquina
    Heeger, Christian-H.
    Lemes, Christine
    Metzner, Andreas
    Mathew, Shibu
    Wissner, Erik
    Wohlmuth, Peter
    Ouyang, Feifan
    Kuck, Karl-Heinz
    Tilz, Roland Richard
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (02) : 147 - 153
  • [23] Effects of rivaroxaban and dabigatran on global hemostasis in patients with atrial fibrillation
    Petkovic, Anica
    Al-Khalili, Faris
    Antovic, Aleksandra
    Ammar, Majeed
    Pruner, Iva
    Vranic, Aleksandra
    Soutari, Nida
    Zdravkovic, Nebojsa
    Malmstrom, Rickard E.
    Jakovljevic, Vladimir
    Antovic, Jovan P.
    BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (04) : 243 - 252
  • [24] Racial and sex differences in optimizing anticoagulation therapy for patients with atrial fibrillation
    Eckman, Mark H.
    Wise, Ruth
    Leonard, Anthony C.
    Baker, Pete
    Ireton, Rob
    Harnett, Brett M.
    Dixon, Estrelita
    Awosika, Bi
    Ezigbo, Chika
    Flaherty, Matthew L.
    Adejare, Adeboye
    Knochelmann, Carol
    Mardis, Rachael
    Wright, Sharon
    Gummadi, Ashish
    Becker, Richard
    Schauer, Daniel P.
    Costea, Alexandru
    Kleindorfer, Dawn
    Sucharew, Heidi
    Costanzo, Amy
    Anderson, Lora
    Kues, John
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2022, 18
  • [25] Addressing racial differences in the management of atrial fibrillation: Focus on black patients
    Ayinde, Hakeem
    Markson, Favour
    Ogbenna, Ugonna Kevin
    Jackson II, Larry
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2024, 116 (05) : 490 - 498
  • [26] Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation
    Providencia, Rui
    Marijon, Eloi
    Albenque, Jean-Paul
    Combes, Stephane
    Combes, Nicolas
    Jourda, Francois
    Hireche, Hassiba
    Morais, Joao
    Boveda, Serge
    EUROPACE, 2014, 16 (08): : 1137 - 1144
  • [27] Dabigatran for stroke prevention in atrial fibrillation
    Hohnloser, S. H.
    Diener, H. -C.
    HAMOSTASEOLOGIE, 2012, 32 (03): : 216 - 220
  • [28] Hospitalized frail elderly patients - atrial fibrillation, anticoagulation and 12 months' outcomes
    Ekerstad, Niklas
    Karlsson, Thomas
    Soderqvist, Sara
    Karlson, Bjorn W.
    CLINICAL INTERVENTIONS IN AGING, 2018, 13 : 749 - 756
  • [29] Racial Differences in Atrial Fibrillation Prevalence and Left Atrial Size
    Marcus, Gregory M.
    Olgin, Jeffrey E.
    Whooley, Mary
    Vittinghoff, Eric
    Stone, Katie L.
    Mehra, Reena
    Hulley, Stephen B.
    Schiller, Nelson B.
    AMERICAN JOURNAL OF MEDICINE, 2010, 123 (04) : 375.e1 - 375.e7
  • [30] Predictors of Gastrointestinal Bleeding Among Patients with Atrial Fibrillation After Initiating Dabigatran Therapy
    Lauffenburger, Julie C.
    Rhoney, Denise H.
    Farley, Joel F.
    Gehi, Anil K.
    Fang, Gang
    PHARMACOTHERAPY, 2015, 35 (06): : 560 - 568
12345